The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment.
O'Meara
S
S
NHS Centre for Reviews and Dissemination, University of York, UK.
Riemsma
R
R
Shirran
L
L
Mather
L
L
ter Riet
G
G
D001067:Appetite Depressants / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003503:Cyclobutanes / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D009765:Obesity / Q000188:drug therapy*; D019057:Quality-Adjusted Life Years; D016032:Randomized Controlled Trials as Topic; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome
D001067:Appetite Depressants; D003503:Cyclobutanes; C058254:sibutramine